Hamidreza Mohammadi | Neuropharmacology | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Hamidreza Mohammadi
Affiliation Mazandaran University of Medical science
Country Iran
Scopus ID 56962768300
Documents 1264
Citations 1370
h-index 24
Subject Area Neuropharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-7053-6850

Hamidreza Mohammadi is affiliated with Mazandaran University of Medical science, Iran, and has contributed to the fields of neuropharmacology, toxicology, oxidative stress research, mitochondrial dysfunction, and nanoparticle-mediated therapeutic development. His research profile reflects interdisciplinary investigations associated with pharmacological toxicology, mitochondrial protection, neuroprotective strategies, and oxidative injury mechanisms in experimental models.[1] His academic contributions include studies related to paraquat-induced neurotoxicity, nanoparticle therapeutics, oxidative stress biomarkers, and toxicological evaluation methodologies that are relevant to modern pharmaceutical and biomedical sciences.[2]

Abstract

The Innovative Research Award recognition highlights the scientific activities and academic contributions of Hamidreza Mohammadi in pharmaceutical toxicology and neuropharmacological sciences. His investigations include oxidative stress modulation, mitochondrial dysfunction analysis, paraquat-induced toxicity, nanoparticle-assisted therapeutic systems, and pharmacological interventions associated with cellular injury mechanisms. Published studies demonstrate collaborative research focused on toxicological pathways, mitochondrial protection, neuroprotective therapies, and nanomedicine-based pharmaceutical applications.[2] These scholarly activities have contributed to the advancement of experimental toxicology and translational pharmaceutical sciences in both preclinical and applied biomedical contexts.

Keywords

Neuropharmacology, Toxicology, Oxidative Stress, Mitochondrial Dysfunction, Paraquat Toxicity, Nanomedicine, Pharmaceutical Sciences, Experimental Pharmacology, Toxicological Research, Therapeutic Nanoparticles.

Introduction

Modern pharmaceutical sciences increasingly emphasize translational research approaches that integrate neuropharmacology, toxicology, nanotechnology, and mitochondrial medicine. Within this scientific environment, Hamidreza Mohammadi has participated in research investigating toxicant-induced cellular injury, neuroprotective mechanisms, oxidative stress pathways, and nanoparticle-assisted drug delivery systems. Several of his studies examine the biological consequences of paraquat exposure, mitochondrial dysfunction, and pharmacological interventions that may reduce oxidative injury in experimental models.[3] These investigations contribute to broader pharmaceutical discussions concerning therapeutic safety, oxidative balance, neurotoxicity prevention, and innovative biomedical strategies.

Research Profile

Hamidreza Mohammadi is associated with Mazandaran University of Medical Sciences and maintains an active academic profile in neuropharmacology and toxicological sciences.[1] His publication record includes collaborative investigations involving mitochondrial protection, toxicant-induced oxidative stress, neuroprotective therapeutics, nanoparticle systems, and pharmacological interventions targeting cellular dysfunction. His Scopus profile reports a substantial scholarly output and citation presence that reflects ongoing scientific engagement in pharmaceutical and biomedical research fields.[1]

Research Contributions

The scientific contributions of Hamidreza Mohammadi include studies focused on paraquat-induced neurotoxicity, oxidative mitochondrial injury, toxicological risk mechanisms, and nanoparticle-assisted therapeutic systems. Research publications have explored mitochondrial oxidative damage, antiemetic neuroprotection, toxicological evaluation of chemicals, and pharmacological mitigation of oxidative injury.[2] Additional work has examined the application of quercetin-loaded nanoparticles, curcumin formulations, and magnesium-based nanocarriers in experimental toxicology models.[4] These contributions collectively support scientific understanding of toxicant-induced physiological disruption and therapeutic intervention strategies.

Publications

Selected publications associated with Hamidreza Mohammadi include research articles in journals related to toxicology, pharmaceutical sciences, oxidative stress biology, and neuropharmacology. His studies investigate paraquat toxicity, mitochondrial dysfunction, nanoparticle therapeutics, and toxicological pharmacology using experimental models and translational biomedical approaches.[2]

Research Impact

The research activities of Hamidreza Mohammadi demonstrate interdisciplinary relevance across pharmaceutical toxicology, neuropharmacology, nanomedicine, and mitochondrial biology. His scholarly output contributes to scientific understanding of oxidative stress-mediated toxicity and therapeutic mitigation strategies. Research findings associated with nanoparticle formulations, mitochondrial protection, and toxicological pharmacology may support future investigations into safer pharmaceutical interventions and experimental therapeutic systems.[5] Citation metrics and publication activity further indicate continued engagement with internationally indexed pharmaceutical research platforms.

Award Suitability

The Innovative Research Award category is aligned with scholarly activities involving emerging pharmaceutical methodologies, toxicological innovation, and interdisciplinary biomedical research. Hamidreza Mohammadi’s work in oxidative stress mechanisms, neuroprotective pharmacology, toxicological assessment, and nanoparticle-based therapeutics reflects research themes commonly associated with contemporary pharmaceutical innovation.[3] His contributions demonstrate relevance to translational pharmaceutical sciences and experimental therapeutic development within academic and biomedical research communities.

Conclusion

Hamidreza Mohammadi has contributed to pharmaceutical and biomedical sciences through research activities centered on neuropharmacology, toxicology, oxidative stress, mitochondrial dysfunction, and nanomedicine. His publication profile reflects continued academic engagement in experimental toxicology and therapeutic investigation. The Innovative Research Award recognition acknowledges these scholarly contributions and their relevance to advancing pharmaceutical research methodologies and translational biomedical understanding.

References

  1. Elsevier. (n.d.). Scopus author details: Hamidreza Mohammadi, Author ID 56962768300. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56962768300
  2. Jahani, R., Pourbahram, P., Seyedabadi, M., Nasiri, F., & Mohammadi, H. (2025). The role of GABAergic receptors in acute, subacute, and withdrawal syndrome on pain and seizure thresholds in mice: A connection to mitochondrial function and oxidative stress in the brain. Toxicology Reports.DOI: https://pubmed.ncbi.nlm.nih.gov/41312119/
  3. Sadeghi, S., Karami, M., Madanchi, H., Yazdian-Robati, R., Seyedabadi, M., Ghasempouri, S. K., Siahposht-Khachaki, A., & Mohammadi, H. (2025). Microfluidic techniques in the development of PLGA nanoparticles: a tri-combination therapy for paraquat-induced cytotoxicity. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfaf133
  4. Khederzadeh, A., Ebrahimnejad, P., Seyedabadi, M., Babaei, A., Talebpour Amiri, F., Aslani, N., Mojarad-Jabali, S., & Mohammadi, H. (2024). Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfae181
  5. Ashari, S., Karami, M., Shokrzadeh, M., Bagheri, A., Ghandadi, M., Ranaee, M., Dashti, A., & Mohammadi, H. (2022). Quercetin ameliorates Di (2-ethylhexyl) phthalate-induced nephrotoxicity by inhibiting NF-κB signaling pathway. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfac006

Daotong Li | Psychopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Daotong Li | Psychopharmacology | Best Researcher Award

Prof. Dr. Daotong Li, China Agricultural University, China

Prof. Dr. Daotong Li is an Associate Professor at China Agricultural University’s College of Food Science and Nutritional Engineering. His research focuses on dietary nutrition, gut microbiota, and food-medicine homology. He has led national research projects and published in top-tier journals like Science Bulletin, Microbiome, and Critical Reviews in Food Science and Nutrition, with over 800 citations and two ESI Highly Cited Papers. 🌱🧬 He has served as Secretary of the International Association of Dietetic Nutrition and Safety and was honored as an “Outstanding Talent” by China Agricultural University in 2022.

Publication Profile

Scopus

Education

Prof. Dr. Daotong Li has an impressive academic background spanning multiple disciplines and institutions. He earned his Ph.D. in Agricultural Products Processing and Storage Engineering from China Agricultural University (2015–2019), with a joint Ph.D. training in Immunology at the renowned Weizmann Institute of Science in Israel (2017–2018) 🌍🔬. Earlier, he completed his Master’s degree in Basic Veterinary Science at South China Agricultural University (2011–2014) 🐾, following a Bachelor’s degree in Animal Inspection and Quarantine from Shanxi Agricultural University (2007–2011) 🐄📘. His diverse educational journey reflects a deep commitment to advancing agricultural and biomedical sciences.

Experience

Prof. Dr. Daotong Li brings valuable experience in both academia and research. Since October 2022, he has been serving as an Associate Professor at the College of Food Science and Nutritional Engineering, China Agricultural University 🏫🥼. Prior to this, from September 2019 to September 2022, he worked as a Postdoctoral Researcher at the School of Basic Medical Sciences, Peking University 🔬🧠. His professional journey highlights a strong dedication to scientific advancement in food science, nutrition, and medical research, positioning him as a key contributor in these interdisciplinary fields .

Awards

Prof. Dr. Daotong Li has received prestigious recognitions for his academic excellence and research contributions. In 2019, he was honored as a “Boya Postdoctoral Fellow” by Peking University, a testament to his outstanding performance during his postdoctoral studies 🔬🎓. Later, in 2022, he was recognized as an “Outstanding Talent” by China Agricultural University 🌟🏫, reflecting his impactful work in food science and nutritional engineering. These accolades not only highlight his dedication to scientific research but also his rising influence in the academic community .

Research Focus

Prof. Dr. Daotong Li focuses on functional foods, nutritional biochemistry, and phytochemistry, with an emphasis on the health benefits of plant-derived compounds. His research explores the nutritional and therapeutic values of superfoods like quinoa 🧡, Houttuynia cordata 🌿, and the sustainable use of fruit and vegetable residues 🍊🥦. He also investigates gut microbiota 🦠, particularly how compounds like acrylamide affect intestinal health and conditions like colitis. His interdisciplinary work spans food science, toxicology, and natural product chemistry, contributing to advancements in functional nutrition 🍽️, sustainable food systems ♻️, and plant-based therapeutics .

Publication Top Notes

Quinoa: Nutritional and phytochemical value, beneficial effects, and future applications

Acrylamide drives amidase-mediated gut dysbiosis to aggravate colitis

The nutritional value, application status and challenges of Houttuynia cordata Thunb (H. cordata)

Sustainable Extraction Technology of Fruit and Vegetable Residues as Novel Food Ingredients

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Assoc Prof Dr Isabel Cristina Céspedes, Escola Paulista de Medicina – UNIFESP, Brazil

Assoc. Prof. Dr. Isabel Cristina Céspedes is a prominent researcher with a focus on genetics, neuroscience, and psychobiology. She obtained her Ph.D. in Morphofunctional Sciences from the University of São Paulo in 2007, specializing in stress-related brain responses in rodents. With postdoctoral work at UNIFESP and extensive teaching experience at universities like USP and UNIP, she explores topics such as substance abuse, epigenetics, and transfusion medicine. She has contributed to numerous publications in journals like Behavioural Brain Research and The Journal of Neuroscience. Her ongoing research investigates the effects of blood transfusions and addiction disorders. 🧠🔬💉📚

Publication Profile

Google Scholar

Educational Background

Assoc. Prof. Dr. Isabel Cristina Céspedes has a distinguished academic background, holding a Ph.D. in Morphofunctional Sciences from the University of São Paulo, specializing in neurobiological responses to stress 🧠. Her postdoctoral research at the Federal University of São Paulo deepened her expertise in genetic and molecular neurobiology 🔬. With a passion for understanding the intricate mechanisms of stress at the molecular level, Dr. Céspedes has contributed significantly to the field, advancing knowledge in neurobiology and stress-related disorders. Her work continues to inspire and shape research in neuroscience and molecular biology 🧬✨.

Leadership in Academia

Dr. Céspedes is an active educator, researcher, and mentor at prestigious institutions such as UNIFESP and USP, where she has made significant contributions to the academic community 📚. With her dedication to higher education, she holds several administrative and leadership roles, guiding academic programs and playing a pivotal part in various committees 🏫💼. Her work reflects a passion for both academic excellence and student mentorship, and her leadership has helped shape the educational landscape at these esteemed institutions 🌟. Through her efforts, Dr. Céspedes continues to inspire and shape future scholars and professionals 🌱.

Research Projects

Dr. Céspedes is conducting pioneering research on the epigenetic effects of blood transfusions, aiming to enhance clinical practices and improve patient outcomes. By examining how transfusions influence gene expression, their work is providing valuable insights into patient health and long-term recovery. Dr. Céspedes’ research contributes to a deeper understanding of the molecular mechanisms involved, which could lead to more personalized medical treatments and better management of transfusion-related complications. This groundbreaking work is opening new avenues in both clinical and genetic research, offering potential advancements in healthcare. 🧬🩸🔬👩‍🔬

Research Focus

Dr. Isabel Cristina Céspedes focuses on neuroscience, particularly in the areas of neuroplasticity, anxiety, stress responses, and neurogenesis. Her research investigates how environmental factors, such as chronic stress and psychological interventions, affect the brain’s defensive responses, Fos immunoreactivity, and hippocampal neurogenesis. She has also explored the effects of substances like alcohol on brain function, including how they alter locomotion and neurocircuitry associated with reward and anxiety. Additionally, Dr. Céspedes contributes to studies on hormonal regulation, particularly cortisol, and its implications for mental health. Her work spans animal models, psychological interventions, and neurobiological mechanisms. 🧠🔬💉📚

Publication Top Notes

Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis

Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis

Una alternativa natural para el tratamiento de la COVID-19

Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis

Environmental enrichment decreases avoidance responses in the elevated T-maze and delta FosB immunoreactivity in anxiety-related brain regions

The Edinger–Westphal nucleus II: Hypothalamic afferents in the rat

Acute restraint differently alters defensive responses and fos immunoreactivity in the rat brain

mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration

Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries